Revenue for the first nine months of 2024 declined year-over-year, but net income improved due to higher margins and a significant asset revaluation. The company maintains a strong order backlog and is focused on R&D in hydrogen and renewables, despite a major contract cancellation post-period.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.